Radionuclide studies in surgical oncology.
Over the last forty years radionuclides have come to play a useful role in diagnosis and treatment of tumours. Radionuclide scintigraphy provides information on morphology and function of tumours; functional studies have become more relevant with advances in instrumentation such as digitised gamma-cameras, single-photon emission tomography (SPECT), position-emission tomography (PET), and with advances in radiopharmaceuticals. A significant contribution in recent years has been the use of radiolabelled antibodies in immunoscintigraphy and immunotherapy; an increasing role is envisaged also for the use of tests for tumour markers in vitro.